DOI QR코드

DOI QR Code

Dissolution Profile Analysis of Hydroxypropyl Methylcellulose-based Vitamin C Tablets

Hydroxypropyl methylcellulose를 활용한 비타민 C 지속성 정제의 용출 특성 분석

  • Received : 2011.12.12
  • Accepted : 2012.03.05
  • Published : 2012.06.30

Abstract

The objective of this study was to develop oral matrix tablets for the sustained release of vitamin C. In this study hydroxypropyl methylcellulose (HPMC) has been utilized as an excipient, as it is one of the most widely used polymers, for use during long periods of time in formations. The vitamin C tablet formulation depends on the molecular weight and concentration of sustained-delivery in HPMC. Anti-oxidants have been added as a dissolution medium in order to prevent vitamin C degradation in water. The dissolution test was carried out in a distilled water medium, and the release model equation was applied to analyze the vitamin C release pattern. The results demonstrated that the release and lasting power of vitamin C tablets, containing HPMC, lasted for more than 12 h.

본 연구에서는 널리 사용되는 수용성 비타민인 비타민 C의 지속성 특성을 발현시키기 위해 HPMC를 사용하여 정제를 제조하였다. 먼저 비타민 C 지속성 정제의 효과적인 용출실험을 진행하기 위해서 용출 용매에 비타민 C의 산화를 방지할 수 있는 항산화제를 첨가함으로써 수분에 의한 비타민 C의 분해를 방지하였다. 비타민 C 지속성 정제의 용출 거동을 확인하기 위해 "대한약전 9개정"과 "경구용의약품의 용출규격 설정 가이드라인"의 용출시험법과 "건강기능식품이 기준 및 규격 고시전문(제2009-153호)"에 근거하여 함량시험과 시간별 용출률을 분석하였다. 분석된 용출 거동은 zero-order release model과 Korsmeyer-Peppas model에 의해 겔 내에서의 활성 성분의 확산과 겔층의 소실로 인한 이의 유리 메카니즘이 분석되었다(37,38). 비타민 C 지속성 정제에 사용된 지속성 HPMC의 사용량이 증가할수록 위장관 운동의 영향에 관계없는 zero-order release의 용출 거동에 가까워짐을 확인하였다. 이는 정제에 사용된 HPMC의 사용량이 높을수록 물을 흡수하여 초기에 겔을 형성하는 속도가 빨라져 용출 속도가 감소함을 보여준다. 점도에 따른 차이는 비타민 C의 높은 수용성 성질 때문에 차이를 보이지 않았으나, 난용성 유효 성분을 적용한 처방에서는 수화능과 겔 형성능에 따라 점도별로 차이가 날 것으로 사료된다. 이는 Korsmeyer-Peppas model에 의한 메커니즘 분석에서 비타민 C의 겔 내 활성 성분의 확산이 겔 층의 소실로 인한 유리보다 다소 우세한 것으로 설명될 수 있다. 이러한 결과를 바탕으로 비타민 C는 수분에 대한 안정성이 부족함에도 지속성 정제로의 개발 및 용출분석이 가능하며, 지속성 고분자로 사용된 HPMC의 사용량에 따라 용출 거동을 조절할 수 있어 1일 2회 내지 1일 1회 요법의 비타민 C 지속성 정제의 제제화와 안정적인 용출분석을 수행할 수 있다. 건강기능식품에 고시된 비타민 C의 정량법인 HPLC법 및 본 연구를 통해 차이가 없음이 확인된 UV spectrophotometer를 사용한 평가방법을 통해 보다 편리하게 수행할 수 있다.

Keywords

References

  1. McGregor GP, Biesalski HK. Rationale and impact of vitamin C in clinical nutrition. Curr. Opin. Clin. Nutr. 9: 697-703 (2006) https://doi.org/10.1097/01.mco.0000247478.79779.8f
  2. Fotherby MD, Williams JC, Forster LA, Craner P, Ferns GA. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J. Hypertens. 18: 411-415 (2000) https://doi.org/10.1097/00004872-200018040-00009
  3. Hamilton IMJ, Gilmore WS, Benzie IFF, Mulholland CW, Strain JJ. Interactions between vitamins C and E in human subjects. Brit. J. Nutr. 84: 261-267 (2000) https://doi.org/10.1017/S0007114500001537
  4. Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose serum lipids & serum insulin in type 2 diabetes patients. Indian J. Med. Res. 126: 471-474 (2007)
  5. Audera C, Patulny RV, Sander BH, Douglas RM. Mega-dose vitamin C in treatment of the common cold a randomised sustained trial. Med. J. Aust. 175: 359-362 (2001)
  6. Braun BL, Fowles JB, Solberg L, Kind E, Healey M, Anderson R. Patient beliefs about the characteristics, causes, and care of the common cold. J. Fam. Practice 49: 153-156 (2000)
  7. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch. Intern. Med. 167: 1610-1618 (2007) https://doi.org/10.1001/archinte.167.15.1610
  8. Douglas RM, Hemila H, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane DB Syst. Rev. 18: CD000980 (2007)
  9. Dwyer JH, Merz NB, Shirocre AM, Nordstrom CK, Dwyer KM. Progression of early atherosclerosis and intake of vitamin C and vitamin E from supplements and food. The Los Angeles Atherosclerosis Study. Circulation 103: 1365 (2001)
  10. Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy of Science, Washington, DC, USA. pp. 95-185 (2000)
  11. Kaur B, Rowe BH, Ram FS. Vitamin C supplementation for asthma. Cochrane DB Syst. Rev. 21: CD000993 (2009)
  12. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. EPIC 357: 657-663 (2001)
  13. Kompauer I, Heinrich J, Wolfram G, Linseisen J. Association of carotenoids, tocopherols, and vitamin C in plasma with allergic rhinitis and allergic sensitization in adults. Public Health Nutr. 9: 472-479 (2006)
  14. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes, and endothelial dysfunction. Cardiovasc. Res. 47: 457-464 (2000) https://doi.org/10.1016/S0008-6363(00)00054-7
  15. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103: 1863-1868 (2001) https://doi.org/10.1161/01.CIR.103.14.1863
  16. Lykkesfeldt J, Christen S, Wallock LM, Chang HH, Jacob RA, Ames BN. Ascorbate is depleted by smoking and repleted by moderate supplementation: A study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am. J. Clin. Nutr. 71: 530-536 (2000) https://doi.org/10.1093/ajcn/71.2.530
  17. Masaki H. Role of antioxidants in the skin: anti-aging effects. J. Dermatol. Sci. 58: 85-90 (2010) https://doi.org/10.1016/j.jdermsci.2010.03.003
  18. Masaki KH, Losonczy KG, Izmirlian G. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54: 1265-1272 (2000) https://doi.org/10.1212/WNL.54.6.1265
  19. Padayatty SJ, Levine M. Reevaluation of ascorbate in cancer treatment: Emerging evidence, open minds and serendipity. J. Am. Coll. Nutr. 19: 423-425 (2000) https://doi.org/10.1080/07315724.2000.10718941
  20. Ram FS, Rowe BH, Kaur B. Vitamin C supplementation for asthma. Cochrane DB Syst. Rev. 3: CD000993 (2004)
  21. Takkouche B, Regueira-Mendez C, Garcia-Closas R, Figueiras A, Gestal-Otero JJ. Intake of vitamin C and zinc and risk of common cold: A cohort study. Epidemiology 13: 38-44 (2002) https://doi.org/10.1097/00001648-200201000-00007
  22. Tofler GH, Stec JJ, Stubbe I, Beadle J, Feng D, Lipinska I, Taylor A. The effect of vitamin C supplementation on coagulability and lipid levels in healthy male subjects. Thromb. Res. 100: 35-41 (2000) https://doi.org/10.1016/S0049-3848(00)00317-0
  23. National Academy of Science. Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals, Food and Nutrition Board, Institute of Medicine, National Academies, National Academy of Science, Washington, DC, USA (2004)
  24. KFDA, KNS. Risk assessment instruction of vitamin and mineral used on health functional food. Korea Food Drug Administration, Seoul, Korea (2007)
  25. Jeong SC, Chon SK, Jo YH, Kim MS, Lee B, Khang G and Lee HB. The effect of bead size and drug solubility on drug release from osmotic granule delivery system for nifedipine. Polymer Korea 29: 288-293 (2005)
  26. James LF, Rubinstein MH, McCau l F, Hogan JE, Edgar PJ. Importance of drug type, tablet shape, and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int. J. Pharm. 40: 223-234 (1987) https://doi.org/10.1016/0378-5173(87)90172-4
  27. Siepmann J, Kranz H, Bodmeier R, Peppas NA. HPMC-Matrices for controlled drug delivery: A new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm. Res. 16: 1748-1756 (1999) https://doi.org/10.1023/A:1018914301328
  28. Chiwele I, Johes BE, Podczeck F, Chiwele I, Jones BE, Podczeck F. The shell dissolution of various empty hard capsules. Chem. Pharm. Bull. 48: 951-956 (2000) https://doi.org/10.1248/cpb.48.951
  29. Kim W, Song BJ, Kim DS, Kim SJ, Lee SK, Kim HL, Lee D, Khang G. Effect of the viscosity of (hydroxypropyl)methyl cellulose on dissolution rate of alfuzosin-HCl granule tablet. Polymer Korea 34: 269-273 (2010)
  30. Rao YM, Veni JK, Jayasagar G. Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev. Ind. Pharm. 27: 759-766 (2001) https://doi.org/10.1081/DDC-100107239
  31. Sarfaraz KN. Handbook of Pharmaceutical Manufacturing Formulations, Compressed Solid Products. 2nd ed. Informa Healthcare, London, UK (2009)
  32. Khan GM, Zhu JB. Studies on drug release kinetics from ibuprofen- carbomer hydrophilic matrix tablets: Influence of co-excipients on release rate of the drug. J. Control. Release 57: 197-203 (1999) https://doi.org/10.1016/S0168-3659(98)00122-9
  33. Mitchell K, Ford JL, Armstrong DJ, Elliot PNC, Hogan JE, Roston C. The influence of substitution type on the performance of methylcellulose and hydroxypropyl methylcellulose in gels and matrices. Int. J. Pharm. 100: 143-154 (1993) https://doi.org/10.1016/0378-5173(93)90085-T
  34. Tahara, K, Yamamoto K, Nishihata T. Overall mechanism behind matrix sustained-release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J. Control. Release 35: 59-66 (1995) https://doi.org/10.1016/0168-3659(95)00021-Y
  35. Ueberreiter K, Asmussen F. Velocity of dissolution of polymers I. J. Polymer Sci. 57: 187-198 (1962) https://doi.org/10.1002/pol.1962.1205716515
  36. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13: 123-133 (2001) https://doi.org/10.1016/S0928-0987(01)00095-1
  37. Korsmeyer RW, Gunny R, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 15: 25-35 (1983) https://doi.org/10.1016/0378-5173(83)90064-9
  38. Langer RS, Peppas NA. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2: 201-214 (1981) https://doi.org/10.1016/0142-9612(81)90059-4

Cited by

  1. Preparation of quercetin and rutin-loaded ceramide liposomes and drug-releasing effect in liposome-in-hydrogel complex system vol.435, pp.3, 2013, https://doi.org/10.1016/j.bbrc.2013.04.093
  2. Development of Porous Cellulose-Hydrogel System for Enhanced Transdermal Delivery of Quercetin and Rutin vol.37, pp.3, 2013, https://doi.org/10.7317/pk.2013.37.3.347